Alltech Teams With ProGnosis on Mycotoxin Testing
The alliance links ProGnosis rapid test strips with Alltech's RAPIREAD platform to improve mycotoxin risk analysis.
Updated on Nov. 5, 2026 in Agriculture
Alltech, a global leader in animal health and nutrition, announced an alliance with ProGnosis Biotech to strengthen mycotoxin testing and analysis. The collaboration connects ProGnosis test results with Alltech RAPIREAD to provide data interpretation and actionable insights.
Why it matters
Weather changes such as drought, heat stress and excessive rainfall influence crop quality and favor mycotoxin development, and mycotoxin risks continue to evolve across regions worldwide. The partnership aims to pair rapid testing with localized intelligence to support more informed decisions.
The announcement contained no quantitative operational or financial metrics. The alliance's initial phase is focused on Europe, the Middle East and Africa, with no further scope figures disclosed.
The players
Alltech
Alltech is a global leader in animal health and nutrition that offers the RAPIREAD platform for assessing mycotoxin risk.
ProGnosis Biotech
ProGnosis Biotech develops fast and simple testing solutions for food safety across the supply chain.
The details
The collaboration fuses ProGnosis rapid lateral flow test strips with the Alltech RAPIREAD platform, which combines rapid testing with automated trend and risk analysis. ProGnosis develops fast, simple food-safety testing solutions used throughout the supply chain, while RAPIREAD helps users understand mycotoxin risk as it relates to animal performance and health.
Timeline
November 5, 2026: Alltech and ProGnosis announce the alliance.
Initial phase: EMEA is the primary focus of the collaboration.
Market Landscape
The partnership extends Alltech's RAPIREAD risk-management platform by layering in ProGnosis's rapid lateral flow testing, which is aimed at feed and food safety across agricultural supply chains. Its initial focus on Europe, the Middle East and Africa reflects the region's growing mycotoxin challenges.
For livestock producers and feed buyers, the partnership points toward faster on-site mycotoxin screening combined with trend-based risk alerts. Practical benefits for end users will depend on how the integrated testing and RAPIREAD analysis are rolled out and priced in practice.
The takeaway
Combining rapid on-site testing with automated risk analysis is a practical way to act on mycotoxin threats before they affect animal health and performance. Producers in affected regions can ask suppliers whether their testing programs include this kind of trend-based monitoring.
Further reading
Explore more coverage of Agriculture to see how crop-quality threats like mycotoxins are shaping farm and feed decisions.
